HUP9701606A2 - Szulbutiamin alkalmazása bizonyos pszichomotoros és pszichointellektuális rendellenességek kezelésére használható gyógyszerkészítmények előállítására - Google Patents
Szulbutiamin alkalmazása bizonyos pszichomotoros és pszichointellektuális rendellenességek kezelésére használható gyógyszerkészítmények előállításáraInfo
- Publication number
- HUP9701606A2 HUP9701606A2 HU9701606A HUP9701606A HUP9701606A2 HU P9701606 A2 HUP9701606 A2 HU P9701606A2 HU 9701606 A HU9701606 A HU 9701606A HU P9701606 A HUP9701606 A HU P9701606A HU P9701606 A2 HUP9701606 A2 HU P9701606A2
- Authority
- HU
- Hungary
- Prior art keywords
- psychomotor
- disorders
- psychointellectual
- sulbutiamine
- treatment
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- CKHJPWQVLKHBIH-ZDSKVHJSSA-N sulbutiamine Chemical compound C=1N=C(C)N=C(N)C=1CN(C=O)C(/C)=C(/CCOC(=O)C(C)C)SS\C(CCOC(=O)C(C)C)=C(\C)N(C=O)CC1=CN=C(C)N=C1N CKHJPWQVLKHBIH-ZDSKVHJSSA-N 0.000 title 1
- 229960003211 sulbutiamine Drugs 0.000 title 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002631 hypothermal effect Effects 0.000 abstract 1
- 208000024714 major depressive disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000000698 schizophrenic effect Effects 0.000 abstract 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- 235000019157 thiamine Nutrition 0.000 abstract 1
- 239000011721 thiamine Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preliminary Treatment Of Fibers (AREA)
Abstract
A találmány tárgya szűlbűtiamin alkalmazása gyógyszerkészítményekelőállítására, amelyekkel bizőnyős pszichőmőtőrikűs és pszichő-intellektűális rendellenességek kezelhetők, melyeket Parkinsőn-kórőspacienseknél, főgyatékős skizőfréneknél, alkőhőlistáknál, nagydepressziósőknál és kórős lehangőltaknál figyelhetők meg. ŕ
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9612112A FR2754178B1 (fr) | 1996-10-04 | 1996-10-04 | Utilisation de la sulbutiamine pour l'obtention de compositions pharmaceutiques utiles dans le traitement de certains troubles psychomoteurs et psycho-intellectuels |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| HU9701606D0 HU9701606D0 (en) | 1997-11-28 |
| HUP9701606A2 true HUP9701606A2 (hu) | 1998-06-29 |
| HUP9701606A3 HUP9701606A3 (en) | 1999-07-28 |
| HU227542B1 HU227542B1 (en) | 2011-08-29 |
Family
ID=9496363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9701606A HU227542B1 (en) | 1996-10-04 | 1997-10-03 | Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psychointellectual disorders |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5863925A (hu) |
| EP (1) | EP0834316B1 (hu) |
| JP (1) | JP4234218B2 (hu) |
| CN (1) | CN1091370C (hu) |
| AT (1) | ATE216884T1 (hu) |
| AU (1) | AU716329B2 (hu) |
| BR (1) | BR9704964A (hu) |
| CA (1) | CA2217463C (hu) |
| DE (1) | DE69712287T2 (hu) |
| DK (1) | DK0834316T3 (hu) |
| ES (1) | ES2176642T3 (hu) |
| FR (1) | FR2754178B1 (hu) |
| HU (1) | HU227542B1 (hu) |
| NO (1) | NO313684B1 (hu) |
| NZ (1) | NZ328915A (hu) |
| PT (1) | PT834316E (hu) |
| ZA (1) | ZA978879B (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20031902A3 (cs) * | 2001-01-31 | 2004-07-14 | Pfizer Products Inc. | Etherové deriváty užitečné jako inhibitory isozymů PDE4 |
| NZ530158A (en) * | 2002-12-20 | 2005-11-25 | Therakos Inc | Irradiation chamber |
| US20070185141A1 (en) * | 2006-02-09 | 2007-08-09 | Tim Patterson | Thiamine composition for enhancement of physical and mental energy, and related method |
| US9463186B2 (en) | 2013-04-15 | 2016-10-11 | Northwestern University | Treatment for dopaminergic disorders |
-
1996
- 1996-10-04 FR FR9612112A patent/FR2754178B1/fr not_active Expired - Fee Related
-
1997
- 1997-09-29 CN CN97122552A patent/CN1091370C/zh not_active Expired - Fee Related
- 1997-10-01 JP JP26831697A patent/JP4234218B2/ja not_active Expired - Fee Related
- 1997-10-02 BR BR9704964A patent/BR9704964A/pt not_active Application Discontinuation
- 1997-10-02 CA CA002217463A patent/CA2217463C/fr not_active Expired - Fee Related
- 1997-10-02 NO NO19974551A patent/NO313684B1/no not_active IP Right Cessation
- 1997-10-03 ZA ZA9708879A patent/ZA978879B/xx unknown
- 1997-10-03 ES ES97402320T patent/ES2176642T3/es not_active Expired - Lifetime
- 1997-10-03 AU AU39928/97A patent/AU716329B2/en not_active Ceased
- 1997-10-03 US US08/943,564 patent/US5863925A/en not_active Expired - Lifetime
- 1997-10-03 EP EP97402320A patent/EP0834316B1/fr not_active Expired - Lifetime
- 1997-10-03 PT PT97402320T patent/PT834316E/pt unknown
- 1997-10-03 AT AT97402320T patent/ATE216884T1/de active
- 1997-10-03 DK DK97402320T patent/DK0834316T3/da active
- 1997-10-03 DE DE69712287T patent/DE69712287T2/de not_active Expired - Lifetime
- 1997-10-03 HU HU9701606A patent/HU227542B1/hu not_active IP Right Cessation
- 1997-10-06 NZ NZ328915A patent/NZ328915A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10130151A (ja) | 1998-05-19 |
| CN1182588A (zh) | 1998-05-27 |
| CA2217463C (fr) | 2003-04-01 |
| FR2754178B1 (fr) | 2002-08-23 |
| ZA978879B (en) | 1998-04-17 |
| ES2176642T3 (es) | 2002-12-01 |
| AU3992897A (en) | 1998-04-09 |
| US5863925A (en) | 1999-01-26 |
| NO313684B1 (no) | 2002-11-18 |
| DK0834316T3 (da) | 2002-08-05 |
| PT834316E (pt) | 2002-08-30 |
| NO974551D0 (no) | 1997-10-02 |
| CA2217463A1 (fr) | 1998-04-04 |
| JP4234218B2 (ja) | 2009-03-04 |
| HUP9701606A3 (en) | 1999-07-28 |
| NZ328915A (en) | 2000-08-25 |
| HU227542B1 (en) | 2011-08-29 |
| EP0834316A1 (fr) | 1998-04-08 |
| DE69712287T2 (de) | 2002-12-12 |
| NO974551L (no) | 1998-04-06 |
| FR2754178A1 (fr) | 1998-04-10 |
| CN1091370C (zh) | 2002-09-25 |
| BR9704964A (pt) | 1998-10-27 |
| HU9701606D0 (en) | 1997-11-28 |
| ATE216884T1 (de) | 2002-05-15 |
| EP0834316B1 (fr) | 2002-05-02 |
| DE69712287D1 (de) | 2002-06-06 |
| AU716329B2 (en) | 2000-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR960700742A (ko) | 아토피성질환 치료약(atopic disease remedy) | |
| AR041725A1 (es) | Prevencion, tratamiento de la enfermedad sinucleinopatica y composicion farmacologica | |
| ATE241365T1 (de) | Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen | |
| DE69400799T2 (de) | Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen | |
| HUP0401867A2 (hu) | A valproinsav-amid és a 2-valproénsav-amid származékainak használata a fájdalommal és a fejfájással járó betegségek kezelésére vagy megelőzésére | |
| ES2173111T3 (es) | Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos. | |
| FR2721516B1 (fr) | Nouvelles utilisations d'un complexe à base de phospholipides cérébraux en thérapeutique et dans l'alimentation. | |
| BR9913955A (pt) | Composição oftalmológica confortável e de liberação sustentada e método para terapia ocular | |
| HUP9700806A2 (hu) | Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására | |
| ATE311191T1 (de) | Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen | |
| DE60129322D1 (de) | Apoptotische körper zur verwendung in der behandlung von neurodegenerativen und sonstigen nervenerkrankungen | |
| DE69928521D1 (de) | Cabergolin und pramipexol zur behandlung von krankheiten des zentralnervensystems, insbesondere parkinsonscher krankheit | |
| HUP9701606A2 (hu) | Szulbutiamin alkalmazása bizonyos pszichomotoros és pszichointellektuális rendellenességek kezelésére használható gyógyszerkészítmények előállítására | |
| FR2754818B1 (fr) | Nouveaux derives bi-aromatiques du dibenzofuranne et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetique | |
| HUP0300566A2 (hu) | Galantamin alkalmazása az Alzheimer-kórral összefüggő neuropszichiátriai viselkedésformák terápiájában | |
| BR0313503A (pt) | Método de tratamento de sìndrome das pernas inquietas, uso do antagonista de receptor da adenoina a2a, agente terapêutico para sìndrome das pernas inquietas, e, método de tratamento da mioclonia noturna | |
| TR199901385T2 (xx) | Piperidin t�revleri. | |
| HUP9701284A2 (hu) | 2,3-Benzodiazepin-származékok felhasználása az endogén opioid rendszerrel összefüggő betegségek és állapotok kezelésére, és megelőzésére alkalmas gyógyászati készítmények előállítására | |
| HUP0102116A2 (hu) | Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása | |
| MY103584A (en) | 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
| IT1246050B (it) | Impiego dell'eptastigmina nella terapia dell'ictus cerebrale. | |
| RS49595B (sr) | Primena 2-fenil-1,2- benzizoselenazol-3(2h)-ona za izradu farmaceutskog preparata za lečenje alchajmerove bolesti | |
| SE9704451D0 (sv) | New method and compositions for the treatment of autoimmune diseases | |
| NO954984L (no) | Ny anvendelse av Ambasilide | |
| RU94016144A (ru) | Средство для лечения больных болезнью рейтера |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of definitive patent protection due to non-payment of fees |